AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 73 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,355,000 | +21.6% | 1,505,090 | 0.0% | 0.00% | – |
| Q3 2016 | $1,114,000 | -42.6% | 1,505,090 | 0.0% | 0.00% | – |
| Q2 2016 | $1,942,000 | -26.6% | 1,505,090 | +27.9% | 0.00% | – |
| Q1 2016 | $2,647,000 | -35.7% | 1,176,504 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $4,118,000 | +20.7% | 1,176,504 | -0.4% | 0.00% | 0.0% |
| Q3 2015 | $3,412,000 | +11.0% | 1,180,671 | -9.0% | 0.00% | – |
| Q2 2015 | $3,075,000 | -75.6% | 1,297,561 | -22.4% | 0.00% | -100.0% |
| Q1 2015 | $12,592,000 | +118.0% | 1,672,276 | -0.7% | 0.00% | +100.0% |
| Q4 2014 | $5,775,000 | -2.7% | 1,683,575 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $5,934,000 | -49.8% | 1,681,107 | +18.8% | 0.00% | -50.0% |
| Q2 2014 | $11,816,000 | +29.0% | 1,415,146 | -1.9% | 0.00% | 0.0% |
| Q1 2014 | $9,161,000 | +15.0% | 1,442,699 | +29.1% | 0.00% | +100.0% |
| Q4 2013 | $7,968,000 | +7.9% | 1,117,467 | +13.5% | 0.00% | 0.0% |
| Q3 2013 | $7,383,000 | +10.7% | 984,397 | -14.8% | 0.00% | 0.0% |
| Q2 2013 | $6,668,000 | – | 1,155,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $137,000 | 0.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $441,000 | 0.14% |
| CVA Family Office, LLC | 1,137,920 | $535,000 | 0.13% |
| Cypress Capital Management LLC (WY) | 179,525 | $84,000 | 0.10% |
| Willis Investment Counsel | 2,075,840 | $976,000 | 0.05% |
| NTB Financial Corp | 146,100 | $69,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $296,000 | 0.04% |
| Helen Stephens Group, LLC | 117,222 | $55,000 | 0.04% |
| COURIER CAPITAL LLC | 464,356 | $218,000 | 0.02% |
| Western Wealth Management, LLC | 946,800 | $444,000 | 0.02% |